Skip to main content

Table 2 Survival analyses of overall survival for extremity liposarcoma patients

From: Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study

  Univariate analysis Multivariate analysis
P HR 95.0% CI P
Age
  < 65 Reference Reference    
 65–76 < 0.001 1.91 1.41–2.58 < 0.001
  > 76 < 0.001 5.64 4.23–7.53 < 0.001
Tumor size
  < 11.1 Reference Reference    
 11.1–23.5 0.022 1.69 1.29–2.22 < 0.001
  > 23.5 < 0.001 2.52 1.77–3.57 < 0.001
Race
 Black Reference     
 Other 0.426     
 White 0.668     
Sex
 Female Reference Reference   
 Male 0.002 1.43 1.11–1.84 0.006
Histological type
 Liposarcoma, NOS Reference     
 Liposarcoma, well differentiated 0.001     
 Myxoid liposarcoma 0.327     
 Round cell liposarcoma 0.005     
 Pleomorphic liposarcoma < 0.001     
 Mixed liposarcoma 0.256     
 Fibroblastic liposarcoma 0.951     
 Dedifferentiated liposarcoma < 0.001     
AJCC
 I/II Reference     
 III/IV < 0.001     
T
 T1 Reference     
 T2 0.273     
N
 N0 Reference    
 N1 0.063    
M
 M0 Reference Reference   
 M1 < 0.001 4.97 2.92–8.46 < 0.001
Surgery
 No Reference Reference   
 Yes < 0.001 0.33 0.20–0.55 < 0.001
Radiotherapy
 No Reference     
 Yes < 0.001     
Chemotherapy
 No Reference     
 Yes < 0.001     
Primary site
 Lower extremity Reference     
 Upper extremity 0.730     
Grade
 I Reference Reference    
 II 0.312 1.83 1.22–2.74 0.004
 III < 0.001 4.90 3.53–6.80 < 0.001
 IV < 0.001 5.85 4.27–8.02 < 0.001
  1. HR Hazard ratio, CI Confidence interval, AJCC American Joint Committee on Cancer